Pelthos Insider RSU Purchase Signals Confidence Ahead of 2026 CT2000 Trial
Pelthos insider RSU grant shows board confidence amid volatile biotech stock—key for investors watching CT2000 trial and regulatory milestones.
4 minutes to read
Pelthos Therapeutics Inc
Insider Buying Fuels Confidence in Pelthos Ocular‑Pain Pipeline
Insider buying at Pelthos shows confidence in its early‑stage ocular pain therapy; see how incremental purchases and trial milestones could drive future value.
5 minutes to read